219 related articles for article (PubMed ID: 15534203)
1. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).
Miura Y; Kainuma M; Jiang H; Velasco H; Vogt PK; Hakomori S
Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16204-9. PubMed ID: 15534203
[TBL] [Abstract][Full Text] [Related]
2. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase.
Aoki H; Satoh M; Mitsuzuka K; Ito A; Saito S; Funato T; Endoh M; Takahashi T; Arai Y
FEBS Lett; 2004 Jun; 567(2-3):203-8. PubMed ID: 15178323
[TBL] [Abstract][Full Text] [Related]
4. Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.
Cohen SB; Waha A; Gelman IH; Vogt PK
Oncogene; 2001 Jan; 20(2):141-6. PubMed ID: 11313943
[TBL] [Abstract][Full Text] [Related]
5. Sialylation and sulfation of lactosylceramide distinctly regulate anchorage-independent growth, apoptosis, and gene expression in 3LL Lewis lung carcinoma cells.
Uemura S; Kabayama K; Noguchi M; Igarashi Y; Inokuchi J
Glycobiology; 2003 Mar; 13(3):207-16. PubMed ID: 12626418
[TBL] [Abstract][Full Text] [Related]
6. GM3 and cancer.
Hakomori SI; Handa K
Glycoconj J; 2015 Feb; 32(1-2):1-8. PubMed ID: 25613425
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new liver-specific c-type mRNA transcriptional variant for mouse ST3GAL5 (GM3/GM4 synthase).
Shishido F; Uemura S; Nitta T; Inokuchi JI
Glycoconj J; 2017 Oct; 34(5):651-659. PubMed ID: 28808804
[TBL] [Abstract][Full Text] [Related]
8. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor.
Toledo MS; Suzuki E; Handa K; Hakomori S
J Biol Chem; 2005 Apr; 280(16):16227-34. PubMed ID: 15710618
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of genes upregulated in cells transformed by v-Jun.
Fu SL; Waha A; Vogt PK
Oncogene; 2000 Jul; 19(31):3537-45. PubMed ID: 10918612
[TBL] [Abstract][Full Text] [Related]
10. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy.
Ono M; Handa K; Sonnino S; Withers DA; Nagai H; Hakomori S
Biochemistry; 2001 May; 40(21):6414-21. PubMed ID: 11371204
[TBL] [Abstract][Full Text] [Related]
11. Expression cloning of mouse cDNA of CMP-NeuAc:Lactosylceramide alpha2,3-sialyltransferase, an enzyme that initiates the synthesis of gangliosides.
Fukumoto S; Miyazaki H; Goto G; Urano T; Furukawa K; Furukawa K
J Biol Chem; 1999 Apr; 274(14):9271-6. PubMed ID: 10092602
[TBL] [Abstract][Full Text] [Related]
12. Cell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13.
Toledo MS; Suzuki E; Handa K; Hakomori S
J Biol Chem; 2004 Aug; 279(33):34655-64. PubMed ID: 15143068
[TBL] [Abstract][Full Text] [Related]
13. [Stable transfection of DAOY cells with a GM3 synthase antisense construct and transient reduction in ganglioside content].
Shevchuk NA; Manela J; Nusinovich EA; Ladisch S
Biomed Khim; 2006; 52(3):245-57. PubMed ID: 16898583
[TBL] [Abstract][Full Text] [Related]
14. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin CD9 is a "proteolipid," and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility.
Kawakami Y; Kawakami K; Steelant WF; Ono M; Baek RC; Handa K; Withers DA; Hakomori S
J Biol Chem; 2002 Sep; 277(37):34349-58. PubMed ID: 12068006
[TBL] [Abstract][Full Text] [Related]
16. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
Hussain S; Kilbey A; Gillespie DA
Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
[TBL] [Abstract][Full Text] [Related]
17. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
Bader AG; Hartl M; Bister K
Virology; 2000 Apr; 270(1):98-110. PubMed ID: 10772983
[TBL] [Abstract][Full Text] [Related]
18. Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion.
Allende ML; Li J; Darling DS; Worth CA; Young WW
Glycobiology; 2000 Oct; 10(10):1025-32. PubMed ID: 11030748
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin.
Wang XQ; Sun P; Paller AS
J Biol Chem; 2003 Jul; 278(28):25591-9. PubMed ID: 12724312
[TBL] [Abstract][Full Text] [Related]
20. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells.
Satoh M; Ito A; Nojiri H; Handa K; Numahata K; Ohyama C; Saito S; Hoshi S; Hakomori SI
Int J Oncol; 2001 Oct; 19(4):723-31. PubMed ID: 11562747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
